Together these findings indicate that MCC950 potently suppresses NP3 inflammasome-mediated IL-1β responses in systemic immune cells from all patients with asthma irrespective of disease severity and sex or obesity status. This evidence concerns the gene IL1B and obesity due to melanocortin 4 receptor deficiency.